Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Selling-General-and-Administrative" stands at 193.15 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the lowest value since 09/30/2014.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -72.65 percent compared to the value the year prior.
The 1 year change in percent is -72.65.
The 3 year change in percent is -64.73.
The 5 year change in percent is -60.42.
The 10 year change in percent is -49.53.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Selling General and Administrative | 905,699,262,464.00 |
![]() | Johnson & Johnson - Selling General and Administrative | 486,508,953,600.00 |
![]() | AbbVie Inc - Selling General and Administrative | 399,570,305,024.00 |
![]() | Roche Holding AG - Selling General and Administrative | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Selling General and Administrative | 280,205,508,085.11 |